Acyclovir may modulate clonal expansion of CD8+ lymphocytes induced by the Cytomegalovirus antigen;El aciclovir puede modular la expansion clonal de linfocitos CD8+ inducida por antigeno de Citomegalovirus

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 17, Issue 8, 1999, Pages 390-393

  Gavilán, Fuensanta ^a   Caballero, Juliana ^a   Cárdenas, Manuel ^a   Moreno, Javier ^a   Martínez, Lucía ^a   Gallego, Carolina ^a   Sánchez Guijo, Pedro ^a   Torre Cisneros, Julián ^a  

^a Hospital Universitario Reina Sofia Cordoba   (Argentina)

Author keywords

Acyclovir; Cytomegalovirus; Immunomodulation effect

Indexed keywords

ACICLOVIR; CD4 ANTIGEN; CD8 ANTIGEN; VIRUS ANTIGEN;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MONONUCLEAR CELL; T LYMPHOCYTE SUBPOPULATION; VIRUS CELL INTERACTION;

ACYCLOVIR; ADULT; ANTIGENS, VIRAL; ANTIVIRAL AGENTS; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CELLS, CULTURED; CLONE CELLS; CYTOMEGALOVIRUS; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 0032692817     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Bessler H, Straussberg R, Djaldetti R, Salmon H. The effect of acyclovir on the proliferative capacity of mononuclear cells from patients with chronic lymphocytic leukemia. Irs J Med Sci 1996; 32: 1.228-1.231.
2. Koziel MJ, Walker BD. Viruses, chemotherapy and immunity. Parasitology 1992; 105: 85-92.
3. Lafferty WE, Brewer LA, Corey L. Alteration of lymphocyte transformation response to herpes simplex virus infection therapy. Antimicrob Agents Chemother 1984; 26: 887-891.
4. Ljungman P, Wilczek H, Gahrton G, Powles RL, Milpied N, Kho P et al. Long-term acyclovir prophylaxis in bone marrow transplant recipients and lymphocyte proliferation responses to herpes virus antigens in vivo. Bone Marrow Transplant 1986; 1: 185-192.
5. Steele RW, Mormer DJ, Keeny RE. Comparative in vitro immunotoxicology of acyclovir and other antiviral agents. Infect Inmun 1980; 28: 957-962.
6. Bowden RA, Digel J, Reed AC, Meyers JD. Immunosuppressive effects of ganciclocir on in vivo lymphocyte responsses. J Infect Dis 1987; 156: 899-903.
7. Torre Cisneros J, Caballero J, Briceno J, Ramírez R, Kindelán J, Sánchez Guijo P. Immunomodulatory effect of acyclovir on CD8T cells proliferation and citokines production induced by Cytomegalovirus and Herpex simplex antigens. Resumen H032. Nueva Orleans: 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1996.
8. Reussepp P, Ridell SR, Meyers JD, Greemberg PD. Cytotoxic T limphocyte response to cytomegalovirus after human allogenic bone marrow transplantation: pattern of recovery and correlation with eytomegalovirus infection and disease. Blood 1991; 78: 1.373-1.380.
9. Grundy JE, Shanley JD, Griffiths JD, Is Cytomegalovirus interstitial pneumonitis in transplant recipients and immunological condition? Lancet 1987; 31: 996-998.
10. Kadima N, Craighedd JE. T-lymphocyte effects on murine Cytomegalovirus pulmonary infection. Am J Pathol 1990; 137: 907-912.
11. Levin MJ, Leary PL, Arbeit RD. Effect of acyclovir on the proliferation of human fibroblasts and peripheral blood mononuclear cells. Antimicrob Agents Chemother 1980; 17: 947-953.
12. Conchoud C, Cucherat M, Haugh M, Ponleil-Noble C. Cytomegalovirus prophylaxis with antiviral agents in solid organ transplantation: a meta-analysis. Transplantation 1998; 15: 641-647.
13. Prentice GH, Gluckman E, Powles RL, Lyungman P, Milpied N, Fernández-Rañada JM et al. Impact of long-term acyclovir on cytomegalovirus infection and survival after allogenic bone marrow transplantation. Lancet 1994; 343: 749-753.
14. Whiting JF, Rossi SJ, Hanto DW. Infections complications after OKT3 induction in liver transplantation. Liver Transplant Surg 1997; 3: 563-570.
15. Hibberd PL, Tolkoff-Rubin NE, Cosini AB, Schooley RT, Isaacson D, Doran M et al. Symptomatic Cytomegalovirus disease in the cytomegalovirus seropositive antibody renal transplant recipient treated with OKT3. Transplantation 1992; 53: 68-72.